Researchers use diverse tools to analyze protein structures.

Richard Webby and Edward Hutchinson discuss influenza viruses—the development of new strains, how they mediate virulence, and their threat to human society.

The Scientist checks in on scientists who switched gears to combat the pandemic.

Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.

Glucometers are easy-to-use, cheap, and highly scalable. And they are 100 percent accurate at detecting SARS-CoV-2.

Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.

Some children who experience the severe inflammatory condition after COVID-19 may continue to experience milder problems such as muscle weakness or anxiety even after that period, according to a small observational study in the UK.

Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.

Researchers find that SARS-CoV-2 variants can evade primer-probe sets and recommend that diagnostic assays include multiple targets for reliability.

Explore what researchers can do with Cryo-EM

Data from three studies indicate that fully vaccinated patients are able to stave off severe disease from the B.1.1.7, B.1.351, and P.1 variants.

A modeling study of boarding behavior finds filling the plane from back to front extends the close contact time between passengers and therefore increases the risks posed by air travel.

Kristin Butcher and Mara Cuoto-Rodriguez discuss the development of a nucleic acid hybridization capture-based assay to detect and identify novel SARS-CoV-2 variants.

Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.

Identifying molecular targets for SARS-CoV-2 therapeutics.

Genetic analyses suggest that the virus came from a patient who survived the 2013–2016 West African outbreak.

Sabra Klein, a biologist at Johns Hopkins Bloomberg School of Public Health, describes how SARS-CoV-2 affects men and women differently.

Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.

The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.